John P. Saharek Harrow Health, Inc. (HROW) insider trading activity
John P. Saharek is CEO of ImprimisRx of HARROW HEALTH, INC.. Currently has a direct ownership of 299,663 shares of HROW, which is worth approximately $14.5 Million. The most recent transaction as insider was on Sep 11, 2024, when has been sold 45,140 shares (Common Stock) at a price of $41.37 per share, resulting in proceeds of $1,867,441. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
300K
17.61%
3M change
34.86%
12M change
Total Value Held
$14.5 Million
JOHN P. SAHAREK Transaction History
JPS
John P. Saharek
CEO of ImprimisRx
Nashville, TN